Valvular and Structural Heart Diseases
Pushing boundaries: Implantation of the 34 mm Medtronic CoreValve in patients with a large aortic annulus
Abstract
The relationship between adherence to the recommended CoreValve sizing parameters and clinical outcomes is not well known for the recently released 34 mm valve, which is currently the largest available transcatheter valve. There is a presumed temporal reduction in paravalvular regurgitation in patients who receive an in-range valve, however, certain patients possess annular dimensions that are too large. We therefore describe two patients with annular dimensions larger than the manufacturer recommended range for the 34 mm CoreValve, who despite this underwent transcatheter aortic valve replacement with excellent clinical outcomes.
CONFLICT OF INTEREST
Dr. Salemi and Dr. Wong disclose a financial relationship with Edwards Lifesciences.
